Objective: Whereas medical treatment remains the "gold standard" for acute aortic syndrome (AAS), mortality remains high. Thoracic endovascular aortic repair (TEVAR) is increasingly used for AAS, a spectrum of disease that includes complicated type B aortic dissection, penetrating aortic ulcer, and intramural hematoma (IMH). We report our institutional outcomes after TEVAR for AAS.
Resuscitative Endovascular Balloon Occlusion of the Aorta and Thoracic Endograft Placement for Paravisceral Aortic Injury
Yue Gao, MD, Asish Patel, MD, Lisa Schlitzkus, MD, Nitin Garg, MBBS. Department of Surgery, University of Nebraska Medical Center, Omaha, Neb Achievement of hemodynamic stability is a basic tenet of trauma surgery. Hemorrhage represents the most common cause of traumatic death worldwide, and the goal of hemorrhage control is to improve the circulating volume to the benefit of end-organ perfusion. Traditionally, resuscitative thoracotomy with aortic cross-clamping is used in noncompressible torso bleeds; however, resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct in the control of hemorrhage has been advocated in select cases. This case entails a 70-year-old man who suffered an accidental self-inflicted thoracoabdominal gunshot wound and subsequently experienced hemodynamic instability on induction of anesthesia during a planned exploratory laparotomy. Preoperative trauma computed tomography showed paravisceral aortic disruption, and it was believed that the patient's hemodynamic instability was related to this injury. The decision was made to emergently place a REBOA that subsequently resulted in the improvement of vital signs. Stabilization of the patient's vital signs allowed him to undergo repair of his descending thoracic aorta injury using thoracic endovascular aortic repair. This case demonstrates that the use of REBOA can potentially convert a case from an emergent to an urgent basis, permitting the utilization of more controlled intervention. Another benefit of REBOA includes the potential of improving a patient's physiologic function to allow endovascular repair for injuries such as those caused by thoracoabdominal aortic trauma that would otherwise require open intervention. This case highlights how endovascular repair of emergent aortic injury can improve a patient's outcomes for anatomic areas that are difficult to approach in an open fashion. Last, this report provides evidence that the use of endovascular treatment in aortic injuries can be safely employed with the concurrent use of REBOA.
Background: Intramural hematomas (IMHs) of the aorta are a rare variant of aortic dissection without the presence of an intimal flap or defect. Controversy exists as to the optimal management for patients with type A IMH. Our objective was to evaluate the outcomes of surgically and medically managed patients.
Methods: A retrospective review was performed for patients with a radiologic diagnosis (computed tomography or magnetic resonance angiography) of thoracic IMH at our institution between June 2006 and July 2017. IMH was defined as a circular or crescent-shaped thickening without evidence of a free flap or intimal defect.
Results: Thirty-two patients were identified with IMH of the thoracic aorta; 14 involved the ascending aorta (type A), and 18 were isolated to the descending aorta (type B). No differences in age, sex, and medical history were observed between the type A and type B cohorts, with the exception of chronic renal insufficiency being more common in type B patients (P ¼ .024). Four type A IMHs underwent emergent surgical repair; three underwent delayed repair (median, 19 days [5-25 days] Objective: Current reimbursement policy surrounding telemedicine has been cited as a barrier to the adaptation of this care model. The objective of this study was to analyze reimbursement figures for outpatient telemedicine consultation in vascular surgery in an integrated health care system.
Methods: Using an institutional database, a retrospective analysis was performed of the reimbursement information related to payer, adjustment, and denial, and paid and outstanding balances were recorded for each telemedicine visit. Patients underwent synchronous virtual visits and point-of-care ultrasound at three satellite locations of Henry Ford Health System in Michigan. Visit types were new, return, and postoperative. The data were analyzed to determine the breakdown of total billed charges, number of denied claims, reimbursement per payer, reimbursement per patients, and out-of-pocket costs to the patients.
Results: From November 2015 to January 2018, there were 184 virtual clinical encounters. Payers included Aetna U.S. Healthcare, Blue Advantage, Blue Cross Blue Shield, Cofinity Plan, Health Alliance Plan, HAP Medicare Advantage, Humana Medicare Advantage, Medicaid, Medicare, Molina Medicaid HMO, United Healthcare, Blue Care Network, Aetna Better Health of Michigan, Priority Health, and self-pay. Among the 15 payers, reimbursement ranged from 0% to 67% of the total charges billed. Among the 184 virtual visits, a grand total of $22,145 or an average of $120.35 per virtual encounter was collected. The breakdown of charges was 40% adjusted, 41% paid by insurance, 10% paid by patient, and 13% denied. Reasons for denial of payment included noncovered charges, payment included for other prior services, new patient quality not met, not covered by payer, and global period encounters. The average outof-pocket cost to the patients was $12.59 per visit.
Conclusions: These reimbursement data validate the economic potential within this new platform of health care delivery. As our experience with the new business model grows, we expect to see a decrease in the number of denials and an increase in reimbursement from private payers and patients. Within a tertiary care system, telemedicine for chronic vascular diseases has proved to be a viable means to reach a broader population base. Objective: Blood transfusions have been found to increase the risk of postoperative complications in surgical patients. The aim of this study was to investigate the effect of blood transfusions on postoperative morbidity and mortality in patients undergoing lower extremity bypass procedures using the National Surgical Quality Improvement Program database.
Methods:
The National Surgical Quality Improvement Program database was queried for years 2014 to 2016 for lower extremity bypass and angioplasty procedures using Current Procedural Terminology codes 37220 through 37235. Cohorts were based on having received a transfusion or not. Cohorts were case matched according to age, sex, race, smoking, diabetes mellitus, hypertension, chronic obstructive pulmonary disease, congestive heart failure, chronic kidney disease, and ventilator dependence. To assess association between perioperative blood transfusions and postoperative morbidity and mortality, a binary logistic regression test in a stepwise fashion and a two-step cluster were performed.
Results: A total of 3492 patients were included in the final analysis after case matching, with 1164 receiving transfusion. Among patients who underwent lower extremity revascularization, those who received intraoperative or postoperative blood transfusion showed a higher risk of pneumonia (relative risk [RR] , 3.7; P < .001), unplanned reintubation (RR, 4.3; P < .001), prolonged intubation >48 hours (RR, 4.7; P < .001), sepsis (RR, 2.8; P < .001), septic shock (RR, 5.3; P < .001), superficial surgical site infection (RR, 4.1; P < .001), deep surgical site infection (RR, 4; P ¼ .003), organ/space surgical site infection (RR, 5.3; P ¼ .006), acute kidney injury (RR, 7.3; P < .001), deep venous thrombosis or thrombophlebitis (RR, 2.25; P ¼ .015), postoperative myocardial infarction (RR, 4.6; P < .001), cerebrovascular accident or stroke (RR, 2.3; P < .03), and 30-day postoperative mortality (RR, 3.6; P < .001). Of interest, the complications experienced by transfusion were predictable based on preoperative condition. Cluster quality was rated good at 0.8 based on silhouette measure of cohesion and separation. The Table describes the relationship between the patient's preoperative profile and the odds of specific transfusion reactions.
Conclusions: Blood transfusions increase risk of postoperative morbidity and mortality among patients who undergo lower extremity bypass procedures. Complications follow a predictable pattern based on the patient's characteristics, which may aid in care.
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Deleterious Effects of General Anesthesia on Minor Foot Amputations
Martin Walsh, Sungho Lim, MD, Lindsay Gil, MD, Pegge Halandras, MD, Carlos Bechara, MD, Bernadette Aulivola, MD, Paul Crisostomo, MD. Vascular Surgery, Loyola University, Maywood, Ill
Objective: Despite revascularization, antibiotics, and wound care, patients with peripheral arterial disease (PAD) often require partial foot amputation for limb salvage. General anesthesia (GA) is widely known to have deleterious cardiopulmonary effects. We previously demonstrated that GA increases the risk for prolonged ventilation after major amputation. It remains unclear whether GA poses similar increased risk 
